Another clue to the fact that our simple-minded "blusher" is the INSM board spammer are these recent comments under the yousstupid alias -
[ Terry-insm the smartest guy in the room ... OK NOW I C Y . I clinician,so I do backtest and read your old posts- you very stoopid .
Buy der stack and get a life! ]
[ I make da list! I excite! I no terry but every body is! NO BODY Cares! stick to da Insmeed info.
jad99 ,you live here 24/7 or you got team of idiots? Buy der stack! ]
The first use of "Buy der stack" on the INSM board was on June 15 2002, under the mrsandiego alias.
That phrase has also been used on the INSM board by -
- and on the AMLN board by -
All of the above aliases demonstrate that you can change your ID but never your IQ.
I particularly like docmomamln's posting history -
Aug 20 2001 -
[ I am a recent buyer of the stock.(last week)I was referred to the company(and this board)by an investor. ]
Sept 3 2001 -
[ My spelling sometimes is poor. My husband quickly corrected me! ]
Sept 29 2001 -
[ Buying more! Rebecca ]
Jan 27 2002 -
[ thanks, my boyfriend Terry pointed the way with this stock. ]
June 6 2002 -
[ Many of us inflicted with dyslexia, have only been able to use a computer since the advent of the spell checker! ]
July 14 2003 -
[ Please comment,your recent comments concerning INSM,and indirectly AMLN and what you think this may lead to ... Paula ]
And these from mrsandiego -
Aug 29 1999 -
[ My problem is not spelling ,but dyslexia. ]
July 21 2003 -
[ ps- Paula has dropped her ID photo I see,too bad she's a cutie. ]
Guess he never noticed that Paula had also dropped the name he first chose for her :-)
Holacle2002's posting history is littered with other clues, including "I blush" and the GNTA connection.
It's a shame Yahoo no longer permits the use of that second word. Our "blusher" has without doubt intellectual impairment of a severity to warrant that medical classification.
A search on the ACAD board (last three months only) for the word "dwindling" yields just the one post, commencing "I'm completely out of Acadia for now."
The same search on the INSM board yields three not very thorough forgeries - two posted under the be_leaguered alias (mimicking b_leauguered) and one posted under the kvmncdd alias (mimicking kvnmcdd).
You may recall that the forged Reuters report of an FDA warning of an increased risk of death associated with a Shire drug (licensed from Insmed) was also posted under the be_leaguered alias.
How simple-minded does one have to be to fail to appreciate the gravity of that particular forgery?
However it is the posting history for the kvmncdd alias which yields the better clues concerning the owner of the two aliases:
July 31 2014 - Replies to a post under one of *****'s main aliases.
April 10 2014 - Praises *****.
April 15 2014 - Mentions GHDX.
April 15 2014 - Replies to a post under the jad90000 (mimic) alias.
Sept 18 2014 - Leaves a space between the end of a word and an exclamation mark.
Sept 18 2014 - Uses "dont".
Sept 18 2014 - Uses "fourty".
Oct 1 2014 - Replies to a post under the blasedp3l (mimic) alias.
Aug 6 2014 - Replies to an "I blush" post under one of *****'s main aliases.
The posting history for the AMLN id ***** uses here includes the following from April 3 2012 -
[ This has to be the lamest thread yet. How can you be sure a bid was made? !
Even the lame who have little stock investing knowlege should know that the 40 Million shares that covered that day ( yes FOURTY MILLION) shares did it because.......????
they believed a "rumor".... they had no contacts in the industry? they got "scared" ? ]
Was my crime asking you to back up your claim that the Baker Brothers own 49.9999% of GHDX?.
Take a break from spamming the INSM board and do a search for The ignore is a beautiful thing. The third one down is some investor's opinion of someone posting as Holacle2002.
Holacle2002 says the ignore is a beautiful thing. His punctuation is lousy. He posts on the INSM and AMLN boards. He thinks what YOU say is worth reposting. That's gotta be you.
That guy's opinion of you in July 2003 shows you found what your good at and stuck with it.
Genomic Health has had a salesforce and footprint in Europe since breast Cancer indication. There are few "free shares". GHDX did a buyback 3years ago and the float is very low . I am not trying to be confrontive on your points, I laying blame on the companies failure to produce revenues that should have been coming in this year. Revenue growth is now not on track to make them profitable this year. There are more questions than answers with a company that has few retail shareholders. The invitae connection is very strong We shall see...Good Luck
In my experience most take overs occur at the point where it becomes immediately apparent that the acquisition will be accretive to the bottom line. I've only been in GHDX for about a year. During that time they have given guidance of slow revenue growth and losses while they ramp the sales force for prostate and establish a foothold in Europe.
I actually see the recent downdraft as a positive. Many of my most profitable investments have been slammed down as major holders try to trip stop loss sales to free up shares. Either way the next quarter or two should indicate if things break the way GHDX has guided.
Between this piece of #$%$ and VRNG I am down 50K plus. I should have listened to Zip back three years ago.
It may look backwards to you since you are forward looking from here. Because the guidance of 2 years ago failed to produce the expected revenues that should of already started., an investor can be skeptical. I am a long, and I think the price appreciation for shareholders will not come from revenues but from a takeover. One by one the Bakers build these bios up setup the structure and move em out. All the pieces are in place Good Luck
Again this is backward looking. What I'm interested in is whether the forward guidance is correct. I know that they are significantly increasing costs to market in Europe and detail the new prostate test in the US. This is occuring at a time when revenues are growing at low single digit rates. Hence the loss. GHDX is guiding to an inflection point mid year where growth will increase well into the double digits (20% or so). Can you offer a reason why this guidance should not be beleived?
Still indicating double digit Rev growth in 2nd half 2015 and a return to profitability for full yr 2015. Obviously this is based on receipt of CPT reimbursement code for prostate test during the 2nd qtr. They did indicate that they reserve the right to update guidance midyear. You can expect that they will do so if the reimbursement code is not received.
So far I have not seen any reason to doubt the GHDX guidance. Anybody else?
Looks like an attractive opportunity to add shares.
Long position from long ago but today is so silly , I just had to , not much (700 under 26 ) ...but I just had to.
I wonder who sold 1300 shares that lowered the stock by $ 1.33 ;- ) Good luck
Invitae adopted a different approach that not only allows consumers to simply send a sample and get results, but also mandates the test to pass through a medical expert. InVitae Corp (NYSE:NVTA)’s popularity is growing day by day. It conducted 200 billable tests in 1Q2014, and orders surged to 1,100 in 3Q and 1,800 in 4Q2014. Invitae also fetched success with health-care providers. It got approval as a Medicare provider and now is in the process of signing contracts with SelectHealth and Blue Shield.